These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1385 related articles for article (PubMed ID: 28881918)

  • 1. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

  • 2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Vansteenkiste J; De Ruysscher D; Eberhardt WE; Lim E; Senan S; Felip E; Peters S;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi89-98. PubMed ID: 23860613
    [No Abstract]   [Full Text] [Related]  

  • 3. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Crinò L; Weder W; van Meerbeeck J; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v103-15. PubMed ID: 20555058
    [No Abstract]   [Full Text] [Related]  

  • 4. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
    Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
    Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer. Clinical practice guidelines in oncology.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Mar; 2(2):94-123. PubMed ID: 19777701
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-small cell lung cancer clinical practice guidelines in oncology.
    Ettinger DS; Bepler G; Bueno R; Chang A; Chang JY; Chirieac LR; D'Amico TA; Demmy TL; Feigenberg SJ; Grannis FW; Jahan T; Jahanzeb M; Kessinger A; Komaki R; Kris MG; Langer CJ; Le QT; Martins R; Otterson GA; Robert F; Sugarbaker DJ; Wood DE;
    J Natl Compr Canc Netw; 2006 Jul; 4(6):548-82. PubMed ID: 16813724
    [No Abstract]   [Full Text] [Related]  

  • 8. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy.
    Remon J; Soria JC; Peters S;
    Ann Oncol; 2021 Dec; 32(12):1637-1642. PubMed ID: 34481037
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2009 May; 20 Suppl 4():68-70. PubMed ID: 19454467
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
    Passiglia F; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S
    Crit Rev Oncol Hematol; 2020 Apr; 148():102862. PubMed ID: 32062311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 15. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    Felip E; Stahel RA; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Hendriks LE; Kerr KM; Menis J; Mok TS; Nestle U; Passaro A; Peters S; Planchard D; Smit EF; Solomon BJ; Veronesi G; Reck M;
    Ann Oncol; 2023 Apr; 34(4):339-357. PubMed ID: 36872130
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.